Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity

Environment -benign, multicomponent synthetic methodologies are vital in modern pharmaceutical research and facilitates multi -targeted drug development via synergistic approach. Herein, we reported green and efficient synthesis of pyrano[2,3-c]pyrazole fused spirooxindole linked 1,2,3-triazoles using a tea waste supported copper catalyst (TWCu). The synthetic approach involves a one -pot, five -component reaction using N-propargylated isatin, hydrazine hydrate, ethyl acetoacetate, malononitrile/ethyl cyanoacetate and aryl azides as model substrates. Mechanistically, the reaction was found to proceed via in situ pyrazolone formation followed by Knoevenagel condensation, azide alkyne cycloaddition and Michael's addition reactions. The molecules were developed using structure -based drug design. The primary goal is to identifying anti -oxidant molecules with potential ability to modulate alpha-amylase and DPP4 (dipeptidyl-peptidase 4) activity. The anti -oxidant analysis, as determined via DPPH, suggested that the synthesized compounds, A6 and A10 possessed excellent anti -oxidant potential compared to butylated hydroxytoluene (BHT). In contrast, compounds A3, A5, A8, A9, A13, A15, and A18 were found to possess comparable anti -oxidant potential. Among these, A3 and A13 possessed potential alpha-amylase inhibitory activity compared to the acarbose, and A3 further emerged as dual inhibitors of both DPP4 and alpha-amylase with anti -oxidant potential. The relationship of functionalities on their anti -oxidant and enzymatic inhibition was explored in context to their SAR that was further corroborated using in silico techniques and enzyme kinetics.